Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Bioorg Med Chem ; 24(6): 1191-203, 2016 Mar 15.
Artículo en Inglés | MEDLINE | ID: mdl-26874397

RESUMEN

Thio-ether fatty acids (THEFAs), including the parent 2-(tetradecylthio)acetic acid (TTA), are modified fatty acids (FAs) that have profound effects on lipid metabolism given that they are blocked for ß-oxidation, and able to act as peroxisome proliferator-activated receptor (PPAR) agonists. Therefore, TTA in particular has been tested clinically for its therapeutic potential against metabolic syndrome related disorders. Here, we describe the preparation of THEFAs based on the TTA scaffold with either a double or a triple bond. These are tested in cultured human skeletal muscle cells (myotubes), either as free acid or following esterification as phospholipids, lysophospholipids or monoacylglycerols. Metabolic effects are assessed in terms of cellular bioavailabilities in myotubes, by FA substrate uptake and oxidation studies, and gene regulation studies with selected PPAR-regulated genes. We note that the inclusion of a triple bond promotes THEFA-mediated FA oxidation. Furthermore, esterification of THEFAs as lysophospholipids also promotes FA oxidation effects. Given that the apparent clinical benefits of TTA administration were offset by dose limitation and poor bioavailability, we discuss the possibility that a selection of our latest THEFAs and THEFA-containing lipids might be able to fulfill the therapeutic potential of the parent TTA while minimizing required doses for efficacy, side-effects and adverse reactions.


Asunto(s)
Éteres/farmacología , Ácidos Grasos/química , Ácidos Grasos/farmacología , Metabolismo de los Lípidos/efectos de los fármacos , Receptores Activados del Proliferador del Peroxisoma/agonistas , Compuestos de Sulfhidrilo/farmacología , Relación Dosis-Respuesta a Droga , Éteres/síntesis química , Éteres/química , Ácidos Grasos/síntesis química , Humanos , Estructura Molecular , Receptores Activados del Proliferador del Peroxisoma/metabolismo , Relación Estructura-Actividad , Compuestos de Sulfhidrilo/síntesis química , Compuestos de Sulfhidrilo/química
2.
PLoS One ; 12(4): e0175441, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28403174

RESUMEN

BACKGROUND AND AIMS: Physical activity has preventive as well as therapeutic benefits for overweight subjects. In this study we aimed to examine effects of in vivo exercise on in vitro metabolic adaptations by studying energy metabolism in cultured myotubes isolated from biopsies taken before and after 12 weeks of extensive endurance and strength training, from healthy sedentary normal weight and overweight men. METHODS: Healthy sedentary men, aged 40-62 years, with normal weight (body mass index (BMI) < 25 kg/m2) or overweight (BMI ≥ 25 kg/m2) were included. Fatty acid and glucose metabolism were studied in myotubes using [14C]oleic acid and [14C]glucose, respectively. Gene and protein expressions, as well as DNA methylation were measured for selected genes. RESULTS: The 12-week training intervention improved endurance, strength and insulin sensitivity in vivo, and reduced the participants' body weight. Biopsy-derived cultured human myotubes after exercise showed increased total cellular oleic acid uptake (30%), oxidation (46%) and lipid accumulation (34%), as well as increased fractional glucose oxidation (14%) compared to cultures established prior to exercise. Most of these exercise-induced increases were significant in the overweight group, whereas the normal weight group showed no change in oleic acid or glucose metabolism. CONCLUSIONS: 12 weeks of combined endurance and strength training promoted increased lipid and glucose metabolism in biopsy-derived cultured human myotubes, showing that training in vivo are able to induce changes in human myotubes that are discernible in vitro.


Asunto(s)
Metabolismo de los Lípidos , Fibras Musculares Esqueléticas/metabolismo , Adenilato Quinasa/genética , Adenilato Quinasa/metabolismo , Células Cultivadas , Metilación de ADN , Epigénesis Genética , Ácidos Grasos/metabolismo , Glucosa/metabolismo , Humanos , Insulina/fisiología , Proteínas Sustrato del Receptor de Insulina/genética , Proteínas Sustrato del Receptor de Insulina/metabolismo , Masculino , Persona de Mediana Edad , Mitocondrias Musculares/metabolismo , Proteínas Mitocondriales/metabolismo , Fosforilación , Procesamiento Proteico-Postraduccional , Entrenamiento de Fuerza , Transcriptoma
3.
PLoS One ; 10(3): e0119556, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25790476

RESUMEN

About 80% of patients with type 2 diabetes are classified as overweight. However, only about 1/3 of severely obese subjects have type 2 diabetes. This indicates that several severely obese individuals may possess certain characteristics that protect them against type 2 diabetes. We therefore hypothesized that this apparent paradox could be related to fundamental differences in skeletal muscle lipid handling. Energy metabolism and metabolic flexibility were examined in human myotubes derived from severely obese subjects without (BMI 44±7 kg/m2) and with type 2 diabetes (BMI 43±6 kg/m2). Lower insulin sensitivity was observed in myotubes from severely obese subjects with type 2 diabetes. Lipolysis rate was higher, and oleic acid accumulation, triacylglycerol content, and fatty acid adaptability were lower in myotubes from severely obese subjects with type 2 diabetes compared to severely obese non-diabetic subjects. There were no differences in lipid distribution and mRNA and protein expression of the lipases HSL and ATGL, the lipase cofactor CGI-58, or the lipid droplet proteins PLIN2 and PLIN3. Glucose and oleic acid oxidation were also similar in cells from the two groups. In conclusion, myotubes established from severely obese donors with established type 2 diabetes had lower ability for lipid accumulation and higher lipolysis rate than myotubes from severely obese donors without diabetes. This indicates that a difference in intramyocellular lipid turnover might be fundamental in evolving type 2 diabetes.


Asunto(s)
Diabetes Mellitus Tipo 2/patología , Metabolismo de los Lípidos/fisiología , Fibras Musculares Esqueléticas/metabolismo , Obesidad/patología , Diabetes Mellitus Tipo 2/metabolismo , Metabolismo Energético , Ácidos Grasos/metabolismo , Humanos , Lipasa/metabolismo , Lipólisis , Proteínas de la Membrana/metabolismo , Obesidad/metabolismo , Ácido Oléico/metabolismo , Oxidación-Reducción , Perilipina-2 , Perilipina-3 , Fosforilación , Proteínas Proto-Oncogénicas c-akt/metabolismo , Índice de Severidad de la Enfermedad , Triglicéridos/metabolismo , Proteínas de Transporte Vesicular/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA